Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825597) titled 'Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell Carcinoma' on Sept. 13.

Study Type: Observational

Primary Sponsor: Washington University School of Medicine

Condition: Head and Neck Squamous Cell Carcinoma

Intervention: Drug: Indocyanine green

Recruitment Status: Not recruiting

Date of First Enrollment: October 31, 2026

Target Sample Size: 25

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07825597

Published by HT Digital Content Services with permission from Health Daily Digest....